Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Other financing activities (2020 - 2025)

Historic Other financing activities for Zai Lab (ZLAB) over the last 6 years, with Q1 2025 value amounting to $854000.0.

  • Zai Lab's Other financing activities rose 2200.0% to $854000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 10528.57%. This contributed to the annual value of $1.3 million for FY2024, which is N/A changed from last year.
  • Per Zai Lab's latest filing, its Other financing activities stood at $854000.0 for Q1 2025, which was up 2200.0% from $583000.0 recorded in Q4 2024.
  • Zai Lab's Other financing activities' 5-year high stood at $973000.0 during Q1 2021, with a 5-year trough of $1000.0 in Q4 2021.
  • Over the past 3 years, Zai Lab's median Other financing activities value was $583000.0 (recorded in 2024), while the average stood at $567714.3.
  • Examining YoY changes over the last 5 years, Zai Lab's Other financing activities showed a top increase of 3383.77% in 2021 and a maximum decrease of 9997.56% in 2021.
  • Over the past 3 years, Zai Lab's Other financing activities (Quarter) stood at $1000.0 in 2021, then soared by 58200.0% to $583000.0 in 2024, then skyrocketed by 46.48% to $854000.0 in 2025.
  • Its Other financing activities was $854000.0 in Q1 2025, compared to $583000.0 in Q4 2024 and $700000.0 in Q1 2024.